Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling

Genes and Development

Volumn 27, Issue 15, 2013, Pages 1706-1717

  Kitade, Mitsuteru ^a   Factor, Valentina M ^a   Andersen, Jesper B ^a   Tomokuni, Akira ^a   Kaji, Kosuke ^a   Akita, Hirofumi ^a   Holczbauer, Agnes ^a   Seo, Daekwan ^a   Marquardt, Jens U ^a   Conner, Elizabeth A ^a   Lee, Seung Bum ^a   Lee, Yun Han ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EGFR; Lineage commitment; Liver progenitor cells; MET

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH1 RECEPTOR; PROTEIN KINASE B; SCATTER FACTOR; STAT3 PROTEIN;

ADULT STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL RENEWAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC MANIPULATION; HEPATIC PROGENITOR CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER REGENERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL EXPANSION;

EGFR; LINEAGE COMMITMENT; LIVER PROGENITOR CELLS; MET;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; HEPATOCYTES; MICE; MICE, SCID; ONCOGENE PROTEIN V-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STEM CELLS;

EID: 84881052522     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.214601.113     Document Type: Article

References (71)

1. Aguirre A., Rubio ME, Gallo V. 2010. Notch and EGFR pathway interaction regulates neural stem cell number and selfrenewal. Nature 467: 323-327.
2. Alison M. R, Golding MH, Sarraf CE. 1996. Pluripotential liver stem cells: Facultative stem cells located in the biliary tree. Cell Prolif 29: 373-402.
3. Andreu-Agullo C, Morante-Redolat JM, Delgado AC, Farinas I. 2009. Vascular niche factor PEDF modulates Notch-dependent stemness in the adult subependymal zone. Nat Neurosci 12: 1514-1523.
4. Bertotti A., Comoglio PM. 2003. Tyrosine kinase signal specificity: Lessons from the HGF receptor. Trends Biochem Sci 28: 527-533.
5. Birchmeier C., Birchmeier W, Gherardi E, Vande Woude GF. 2003. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925.
6. Bohm F., Kohler UA, Speicher T, Werner S. 2010. Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2: 294-305.
7. Boulter L., Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A., Ridgway RA, Seo SS, Spee B, Van Rooijen N, et al. 2012. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 18: 572-579.
8. Boulter L., Lu WY, Forbes SJ. 2013. Differentiation of progenitors in the liver: A matter of local choice. J Clin Invest 123: 1867-1873.
9. Brill L. M, XiongW, Lee KB, Ficarro SB, Crain A, Xu Y, Terskikh A, Snyder E. Y, Ding S. 2009. Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell 5: 204-213.
10. Burgess A.W. 2008. EGFR family: Structure physiology signalling and therapeutic targets. Growth Factors 26: 263-274.
11. Chen N., Greenwald I. 2004. The lateral signal for LIN-12/ Notch in C. elegans vulval development comprises redundant secreted and transmembrane DSL proteins. Dev Cell 6: 183-192.
12. Cicalese A., Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C., Minucci S, Di Fiore PP, Pelicci PG. 2009. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138: 1083-1095.
13. del Castillo G, Factor VM, Fernandez M, Alvarez-Barrientos A, Fabregat I, Thorgeirsson SS, Sanchez A. 2008. Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro. Am J Pathol 172: 1238-1247.
14. Duncan A. W, Dorrell C, Grompe M. 2009. Stem cells and liver regeneration. Gastroenterology 137: 466-481.
15. Espanol-Suner R, Carpentier R, Van Hul N, Legry V, Achouri Y, Cordi S., Jacquemin P, Lemaigre F, Leclercq IA. 2012. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 143: 1564-1575. e7.
16. Evarts R. P, Hu ZY, Fujio K, Marsden ER, Thorgeirsson SS. 1993. Activation of hepatic stem-cell compartment in the rat: role of transforming growth-factor-a, hepatocyte growth-factor, and acidic fibroblast growth-factor in early proliferation. Cell Growth Differ 4: 555-561.
17. Factor V. M, Radaeva SA, Thorgeirsson SS. 1994. Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol 145: 409-422.
18. Factor V. M, Seo D, Ishikawa T, Kaposi-Novak P, Marquardt JU, Andersen J. B, Conner EA, Thorgeirsson SS. 2010. Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice. PLoS ONE 5: e12739.
19. Fiorotto R., Raizner A, Morell CM, Torsello B, Scirpo R, Fabris L, Spirli C., Strazzabosco M. 2013. Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice. J Hepatol 59: 124-130.
20. Geisler F., Nagl F, Mazur PK, Lee M, Zimber-Strobl U, Strobl LJ, Radtke F., Schmid RM, Siveke JT. 2008. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 48: 607-616.
21. Giannini C., Morosan S, Tralhao JG, Guidotti JE, Battaglia S, Mollier K., Hannoun L, Kremsdorf D, Gilgenkrantz H, Charneau P. 2003. A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector. Hepatology 38: 114-122.
22. Greenbaum L. E, Wells RG. 2011. The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol 43: 222-229.
23. Greulich H., Chen TH, Feng W, Janne PA, Alvarez JV, Zappaterra M, Bulmer SE, Frank DA, Hahn WC, Sellers WR, et al. 2005. Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants. PLoS Med 2: e313.
24. Harper J. A, Yuan JS, Tan JB, Visan I, Guidos CJ. 2003. Notch signaling in development and disease. Clin Genet 64: 461-472.
25. Hasuike S., Ido A, Uto H, Moriuchi A, Tahara Y, Numata M, Nagata K., Hori T, Hayashi K, Tsubouchi H. 2005. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats. J Gastroenterol Hepatol 20: 1753-1761.
26. Huh C. G, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. 2004. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci 101: 4477-4482.
27. Ishikawa T., Factor VM, Marquardt JU, Raggi C, Seo D, Kitade M, Conner EA, Thorgeirsson SS. 2012. Hepatocyte growth factor (HGF)/c-Met signaling is required for stem cell mediated liver regeneration. Hepatology 55: 1215-1226.
28. Jeliazkova P., Jors S, Lee M, Zimber-Strobl U, Ferrer J, Schmid RM, Siveke JT, Geisler F. 2013. Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1. Hepatology 57: 2469-2479.
29. Jensen C. H, Jauho EI, Santoni-Rugiu E, Holmskov U, Teisner B, Tygstrup N., Bisgaard HC. 2004. Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/ preadipocyte factor 1/fetal antigen 1. Am J Pathol 164: 1347-1359.
30. Jo M., Stolz DB, Esplen JE, Dorko K, Michalopoulos GK, Strom SC. 2000. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem 275: 8806-8811.
31. Karp X., Greenwald I. 2003. Post-transcriptional regulation of the E/Daughterless ortholog HLH-2, negative feedback, and birth order bias during the AC/VU decision in C. elegans. Genes Dev 17: 3100-3111.
32. Kolev V., Mandinova A, Guinea-Viniegra J, Hu B, Lefort K, Lambertini C., Neel V, Dummer R, Wagner EF, Dotto GP. 2008. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 10: 902-911.
33. Krejci A., Bernard F, Housden BE, Collins S, Bray SJ. 2009. Direct response to Notch activation: Signaling crosstalk and incoherent logic. Sci Signal 2: ra1.
34. Lee T. C, Threadgill DW. 2009. Generation and validation of mice carrying a conditional allele of the epidermal growth factor receptor. Genesis 47: 85-92.
35. Lee S. B, Seo D, Choi D, Park KY, Holczbauer A, Marquardt JU, Conner E. A, Factor VM, Thorgeirsson SS. 2012. Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells. Stem Cells 30: 997-1007.
36. Li L., Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask B. J, Kuo WL, Cochran J, et al. 1997. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16: 243-251.
37. Ligoxygakis P., Yu SY, Delidakis C, Baker NE. 1998. A subset of notch functions during Drosophila eye development require Su(H) and the E(spl) gene complex. Development 125: 2893-2900.
38. Marquardt J. U, Raggi C, Andersen JB, Seo D, Avital I, Geller D, Lee Y. H, Kitade M, Holczbauer A, Gillen MC, et al. 2011. Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. Hepatology 54: 1031-1042.
39. McCright B, Lozier J, Gridley T. 2002. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129: 1075-1082.
40. Meier-Stiegen F, Schwanbeck R, Bernoth K, Martini S, Hieronymus T, Ruau D, Zenke M, Just U. 2010. Activated Notch1 target genes during embryonic cell differentiation depend on the cellular context and include lineage determinants and inhibitors. PLoS ONE 5: e11481.
41. Michalopoulos G.K. 2010. Liver regeneration after partial hepatectomy: Critical analysis of mechanistic dilemmas. Am J Pathol 176: 2-13.
42. Michalopoulos G. K, DeFrances MC. 1997. Liver regeneration. Science 276: 60-66.
43. Morgenstern J. P, Land H. 1990. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587-3596.
44. Nagy P., Bisgaard HC, Santoni-Rugiu E, Thorgeirsson SS. 1996. In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene. Hepatology 23: 71-79.
45. Nakamura T., Sakai K, Matsumoto K. 2011. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol 26: 188-202.
46. Natarajan A., Wagner B, Sibilia M. 2007. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci 104: 17081-17086.
47. O'Brien LE, Yu W, Tang K, Jou TS, Zegers MM, Mostov KE. 2006. Morphological and biochemical analysis of Rac1 in three-dimensional epithelial cell cultures. Methods Enzymol 406: 676-691.
48. Oda T., Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli D. A, Meltzer PS, Spinner NB, Collins FS, et al. 1997. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16: 235-242.
49. Okabe M., Tsukahara Y, Tanaka M, Suzuki K, Saito S, Kamiya Y, Tsujimura T., Nakamura K, Miyajima A. 2009. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 136: 1951-1960.
50. Preisegger K. H, Factor VM, Fuchsbichler A, Stumptner C, Denk H, Thorgeirsson SS. 1999. Atypical ductular proliferation and its inhibition by transforming growth factor b1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest 79: 103-109.
51. Presnell S. C, Stolz DB, Mars WM, Jo M, Michalopoulos GK, Strom SC. 1997. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-a in rat liver epithelial cells. Mol Carcinog 18: 244-255.
52. Purow B. W, Sundaresan TK, Burdick MJ, Kefas BA, Comeau LD, HawkinsonMP, Su Q, Kotliarov Y, Lee J, ZhangW, et al. 2008. Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Carcinogenesis 29: 918-925.
53. Riehle K. J, Dan YY, Campbell JS, Fausto N. 2011. New concepts in liver regeneration. J Gastroenterol Hepatol 26: 203-212.
54. Roskams T., Katoonizadeh A, Komuta M. 2010. Hepatic progenitor cells: An update. Clin Liver Dis 14: 705-718.
55. Rountree C. B, Barsky L, Ge S, Zhu J, Senadheera S, Crooks GM. 2007. A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells 25: 2419-2429.
56. Schmidt C., Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M., Gherardi E, Birchmeier C. 1995. Scatter factor/ hepatocyte growth factor is essential for liver development. Nature 373: 699-702.
57. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North P. E, Dalton S, Duncan SA. 2010. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51: 297-305.
58. Sparks E. E, Huppert KA, Brown MA, Washington MK, Huppert SS. 2010. Notch signaling regulates formation of the threedimensional architecture of intrahepatic bile ducts in mice. Hepatology 51: 1391-1400.
59. Suzuki A., Zheng YW, Kaneko S, Onodera M, Fukao K, Nakauchi H, Taniguchi H. 2002. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 156: 173-184.
60. Tanaka M., Itoh T, Tanimizu N, Miyajima A. 2011. Liver stem/ progenitor cells: Their characteristics and regulatory mechanisms. J Biochem 149: 231-239.
61. Tanimizu N., Miyajima A. 2004. Notch signaling controls hepatoblast differentiation by altering the expression of liverenriched transcription factors. J Cell Sci 117: 3165-3174.
62. Tanimizu N., Miyajima A, Mostov KE. 2007. Liver progenitor cells develop cholangiocyte-type epithelial polarity in threedimensional culture. Mol Biol Cell 18: 1472-1479.
63. Tchorz J. S, Kinter J, Muller M, Tornillo L, Heim MH, Bettler B. 2009. Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice. Hepatology 50: 871-879.
64. Theise N. D, Saxena R, Portmann BC, Thung SN, Yee H, Chiriboga L., Kumar A, Crawford JM. 1999. The canals of Hering and hepatic stem cells in humans. Hepatology 30: 1425-1433.
65. Thorgeirsson S. S, Grisham JW. 2003. Overview of recent experimental studies on liver stem cells. Semin Liver Dis 23: 303-312.
66. Thorgeirsson S. S, Evarts RP, Bisgaard HC, Fujio K, Hu Z. 1993. Hepatic stem cell compartment: Activation and lineage commitment. Proc Soc Exp Biol Med 204: 253-260.
67. Trusolino L., Bertotti A, Comoglio PM. 2010. MET signalling: Principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 11: 834-848.
68. Tsuda L., Nagaraj R, Zipursky SL, Banerjee U. 2002. An EGFR/ Ebi/Sno pathway promotes delta expression by inactivating Su(H)/SMRTER repression during inductive notch signaling. Cell 110: 625-637.
69. Weglarz T. C, Degen JL, Sandgren EP. 2000. Hepatocyte transplantation into diseased mouse liver: Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. Am J Pathol 157: 1963-1974.
70. Wrobel C. N, Debnath J, Lin E, Beausoleil S, Roussel MF, Brugge JS. 2004. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. J Cell Biol 165: 263-273.
71. Zong Y., Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, Stanger BZ. 2009. Notch signaling controls liver development by regulating biliary differentiation. Development 136: 1727-1739.